Oliver Kummer
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
-
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Bariatric Surgery and Outcomes
- Peripheral Artery Disease Management
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Surgery 6
- Peripheral Artery Disease Management 2
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- Manuel Haschke (8 shared papers)Stephan Krähenbühl (5 shared papers)Felix Hammann (4 shared papers)Jan Harder (2 shared papers)Michael Bodmer (6 shared papers)Jürgen Drewe (3 shared papers)Stephan Krähenbühl (2 shared papers)Henning Usadel (1 shared paper)
- Journals
- Therapeutic Drug Monitoring (3 papers)Journal of Controlled Release (1 paper)British Journal of Cancer (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- SwitzerlandGermany
In The Last Decade
Oliver Kummer
17 papers receiving 510 citations
Peers
Comparison fields: 5 of 64
- Pharmacology 67
- Surgery 200
- Anesthesiology and Pain Medicine 28
- Emergency Medicine 27
- Nephrology 25
Countries citing papers authored by Oliver Kummer
This map shows the geographic impact of Oliver Kummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Kummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Kummer more than expected).
Fields of papers citing papers by Oliver Kummer
This network shows the impact of papers produced by Oliver Kummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Kummer. The network helps show where Oliver Kummer may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Kummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 107 | |
| 2 | 2010 | 72 | |
| 3 | 2007 | 57 | |
| 4 | 2010 | 43 | |
| 5 | 2009 | 39 | |
| 6 | 2007 | 38 | |
| 7 | 2015 | 38 | |
| 8 | 2007 | 34 | |
| 9 | 2005 | 24 | |
| 10 | 2008 | 20 | |
| 11 | 2007 | 16 | |
| 12 | 2007 | 15 | |
| 13 | 2008 | 15 | |
| 14 | 2008 | 13 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 5 | |
| 17 | [Clopidogrel and its salts: any clnical implication?]. | 2010 | 1 |
About Oliver Kummer
Oliver Kummer is a scholar working on Pharmacology, Surgery, Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Oncology, having authored 17 papers that have together received 545 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Peripheral Artery Disease Management (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Epilepsy research and treatment (1 paper), Drug Solubulity and Delivery Systems (1 paper), Pulmonary Hypertension Research and Treatments (1 paper), Analytical Methods in Pharmaceuticals (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Pharmacology (67 citations), Surgery (200 citations), Anesthesiology and Pain Medicine (28 citations), Emergency Medicine (27 citations) and Nephrology (25 citations). Oliver Kummer has collaborated with scholars based in Switzerland and Germany. Frequent co-authors include Manuel Haschke, Stephan Krähenbühl, Felix Hammann, Jan Harder, Michael Bodmer, Jürgen Drewe, Stephan Krähenbühl, Henning Usadel, O. G. OPITZ and H. Henß. Their work appears in journals such as Therapeutic Drug Monitoring, Journal of Controlled Release, British Journal of Cancer, European Journal of Pharmaceutical Sciences and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.